| P50 | author | Robert S Sandler | Q87015965 |
| | Imran Ali | Q37839036 |
| P2093 | author name string | David J Munroe | |
| | Elizabeth L Barry | |
| | John A Baron | |
| | Maria V Grau | |
| | Jiang Gui | |
| | Dennis J Ahnen | |
| | Fred Saibil | |
| | Robert S Bresalier | |
| | Carol Burke | |
| | Leah B Sansbury | |
| | Shirley Tsang | |
| | Gail E McKeown-Eyssen | |
| P2860 | cites work | Nonsteroidal Anti-inflammatory Drugs and Cyclooxygenase-2 Inhibitors for Primary Prevention of Colorectal Cancer: A Systematic Review Prepared for the U.S. Preventive Services Task Force | Q22241141 |
| | Folic Acid for the Prevention of Colorectal Adenomas | Q22252994 |
| | Inflammation and cancer | Q24649640 |
| | Allellic variants in regulatory regions of cyclooxygenase-2: association with advanced colorectal adenoma | Q25255846 |
| | Aspirin and the risk of colorectal cancer in relation to the expression of COX-2. | Q27851408 |
| | Cancer-related inflammation | Q27860907 |
| | Haploview: analysis and visualization of LD and haplotype maps | Q27860955 |
| | Cyclooxygenase in biology and disease | Q27863453 |
| | Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland | Q28140600 |
| | Polymorphisms in prostaglandin synthase 2/cyclooxygenase 2 (PTGS2/COX2) and risk of colorectal cancer | Q28168820 |
| | Protective effect of nonsteroidal anti-inflammatory drugs on colorectal adenomas is modified by a polymorphism in peroxisome proliferator-activated receptor delta | Q28193913 |
| | Prostaglandin H synthase 2 variant (Val511Ala) in African Americans may reduce the risk for colorectal neoplasia | Q28194221 |
| | COX-2 polymorphism, use of nonsteroidal anti-inflammatory drugs, and risk of colon cancer in African Americans (United States) | Q28195167 |
| | A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer | Q28195274 |
| | A randomized trial of aspirin to prevent colorectal adenomas | Q28195296 |
| | Celecoxib for the prevention of sporadic colorectal adenomas | Q28200368 |
| | Celecoxib for the prevention of colorectal adenomatous polyps | Q28200375 |
| | Ornithine decarboxylase polymorphism modification of response to aspirin treatment for colorectal adenoma prevention | Q28200776 |
| | PTGS2 (COX-2) -765G > C promoter variant reduces risk of colorectal adenoma among nonusers of nonsteroidal anti-inflammatory drugs | Q28210376 |
| | Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies | Q28210611 |
| | The use of aspirin for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force | Q28220086 |
| | Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population | Q29614401 |
| | Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas | Q29620630 |
| | Many actions of cyclooxygenase-2 in cellular dynamics and in cancer | Q34539982 |
| | A randomized trial of rofecoxib for the chemoprevention of colorectal adenomas. | Q34572357 |
| | COX-2: a molecular target for colorectal cancer prevention | Q36101515 |
| | Non-COX-2 targets and cancer: expanding the molecular target repertoire of chemoprevention | Q36159503 |
| | Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics | Q36402212 |
| | Cyclooxygenase-2 overexpression correlates with tumour recurrence, especially haematogenous metastasis, of colorectal cancer | Q36641883 |
| | The role of cyclooxygenase-2 and prostaglandins in colon cancer | Q36681718 |
| | Interaction between cyclooxygenase-2 gene polymorphism and dietary n-6 polyunsaturated fatty acids on colon cancer risk: the Singapore Chinese Health Study | Q36695052 |
| | Cyclooxygenase-2 and tumor biology. | Q36716916 |
| | Pro-inflammatory prostaglandins and progression of colorectal cancer | Q36909506 |
| | A review of gene-drug interactions for nonsteroidal anti-inflammatory drug use in preventing colorectal neoplasia | Q37016763 |
| | Convergence of genetic, nutritional and inflammatory factors in gastrointestinal cancers | Q37073885 |
| | Cyclooxygenase 2 polymorphism and colorectal cancer: -765G>C variant modifies risk associated with smoking and body mass index | Q37226327 |
| | Inherited susceptibility to common cancers | Q37324049 |
| | Cyclooxygenase polymorphisms in gastric and colorectal carcinogenesis: are conclusive results available? | Q37342669 |
| | Dietary omega-3 fatty acids, cyclooxygenase-2 genetic variation, and aggressive prostate cancer risk | Q37357993 |
| | New insights into the aetiology of colorectal cancer from genome-wide association studies | Q37478088 |
| | Overexpression of cyclooxygenase-2 correlates with advanced stages of colorectal cancer | Q43498439 |
| | The relationship between cyclooxygenase-2 expression and colorectal cancer. | Q44193470 |
| | PowerMarker: an integrated analysis environment for genetic marker analysis | Q44861765 |
| | Inflammation-related gene polymorphisms and colorectal adenoma | Q45004211 |
| | Arachidonate lipoxygenase (ALOX) and cyclooxygenase (COX) polymorphisms and colon cancer risk | Q45016568 |
| | Genetic polymorphisms of cyclooxygenase-2 and colorectal adenoma risk: the Self Defense Forces Health Study | Q46826891 |
| | Polymorphisms in the genes involved in the arachidonic acid-pathway, fish consumption and the risk of colorectal cancer | Q46947912 |
| | Genetic variability in prostaglandin synthesis, fish intake and risk of colorectal polyps. | Q53337213 |
| | Cyclooxygenase-2 expression: a significant prognostic indicator for patients with colorectal cancer. | Q53362101 |
| | COX-2 is expressed in human pulmonary, colonic, and mammary tumors. | Q53402915 |
| | Expression of cyclooxygenase-1 and -2 in human colorectal cancer | Q53461597 |
| | Regulation of constitutive cyclooxygenase-2 expression in colon carcinoma cells | Q74127393 |
| | Associations of functional polymorphisms in cyclooxygenase-2 and platelet 12-lipoxygenase with risk of occurrence and advanced disease status of colorectal cancer | Q79411107 |
| | Genetic polymorphisms and spontaneous preterm birth | Q79701016 |
| | Protective effect of Cox-2 allelic variants on risk of colorectal adenoma development in African Americans | Q82718017 |
| P433 | issue | 10 | |
| P921 | main subject | aspirin | Q18216 |
| | colorectal adenoma | Q2825480 |
| P304 | page(s) | 2726-2733 | |
| P577 | publication date | 2009-09-15 | |
| P1433 | published in | Cancer Epidemiology, Biomarkers & Prevention | Q326334 |
| P1476 | title | Cyclooxygenase-2 polymorphisms, aspirin treatment, and risk for colorectal adenoma recurrence--data from a randomized clinical trial | |
| P478 | volume | 18 | |